FDA Concludes Existing Regulatory Frameworks for Foods and Supplements Not Appropriate for Cannabidiol, Will Work with Congress on a New Way Forward
Given the growing cannabidiol (CBD) products market, the U.S. Food and Drug Administration convened a high-level internal working...
